175 related articles for article (PubMed ID: 30890055)
21. Collagen turnover biomarkers and systemic right ventricle remodeling in adults with previous atrial switch procedure for transposition of the great arteries.
Lipczyńska M; Szymański P; Kumor M; Klisiewicz A; Hoffman P
PLoS One; 2017; 12(8):e0180629. PubMed ID: 28767656
[TBL] [Abstract][Full Text] [Related]
22. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
[TBL] [Abstract][Full Text] [Related]
23. Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study.
Romero JR; Vasan RS; Beiser AS; Polak JF; Benjamin EJ; Wolf PA; Seshadri S
J Stroke Cerebrovasc Dis; 2008; 17(6):412-7. PubMed ID: 18984437
[TBL] [Abstract][Full Text] [Related]
24. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Matsui T; Kinoshita M
J Am Coll Cardiol; 2001 Apr; 37(5):1228-33. PubMed ID: 11300427
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population.
Sokal A; Lenarczyk R; Kowalski O; Mitrega K; Pluta S; Stabryla-Deska J; Streb W; Urbanik Z; Krzeminski TF; Kalarus Z
Heart Rhythm; 2016 May; 13(5):1088-1095. PubMed ID: 26776557
[TBL] [Abstract][Full Text] [Related]
26. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
[TBL] [Abstract][Full Text] [Related]
27. Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi-Ethnic Study of Atherosclerosis).
Duprez DA; Gross MD; Kizer JR; Ix JH; Hundley WG; Jacobs DR
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475876
[TBL] [Abstract][Full Text] [Related]
28. Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium.
Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
JACC Heart Fail; 2019 Mar; 7(3):204-213. PubMed ID: 30819375
[TBL] [Abstract][Full Text] [Related]
29. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
30. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
Park M; Vittinghoff E; Shlipak MG; Mishra R; Whooley M; Bansal N
Am Heart J; 2014 Dec; 168(6):931-9.e2. PubMed ID: 25458658
[TBL] [Abstract][Full Text] [Related]
31. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
32. Pedal Edema as an Indicator of Early Heart Failure in the Community: Prevalence and Associations With Cardiac Structure/Function and Natriuretic Peptides (MESA [Multiethnic Study of Atherosclerosis]).
Yeboah J; Bertoni A; Qureshi W; Aggarwal S; Lima JA; Kawel-Boehm N; Bluemke DA; Shah SJ
Circ Heart Fail; 2016 Dec; 9(12):. PubMed ID: 27923806
[TBL] [Abstract][Full Text] [Related]
33. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
34. Cyclic Guanosine Monophosphate and Risk of Incident Heart Failure and Other Cardiovascular Events: the ARIC Study.
Zhao D; Guallar E; Vaidya D; Ndumele CE; Ouyang P; Post WS; Lima JA; Ying W; Kass DA; Hoogeveen RC; Shah SJ; Subramanya V; Michos ED
J Am Heart Assoc; 2020 Jan; 9(2):e013966. PubMed ID: 31928156
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of serum PIIINP, MMP1 and TIMP1 levels in hypertensive patients: a community-based prospective cohort study.
Agrinier N; Thilly N; Boivin JM; Dousset B; Alla F; Zannad F
Fundam Clin Pharmacol; 2013 Oct; 27(5):572-80. PubMed ID: 22788708
[TBL] [Abstract][Full Text] [Related]
36. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
[TBL] [Abstract][Full Text] [Related]
37. Circulating Aminoterminal Propeptide of Type III Procollagen as a Biomarker of Cardiovascular Events in Patients Undergoing Hemodialysis.
Nishimura M; Tokoro T; Takatani T; Sato N; Hashimoto T; Kobayashi H; Ono T
J Atheroscler Thromb; 2019 Apr; 26(4):340-350. PubMed ID: 30111669
[TBL] [Abstract][Full Text] [Related]
38. Resistin, adiponectin, and risk of heart failure the Framingham offspring study.
Frankel DS; Vasan RS; D'Agostino RB; Benjamin EJ; Levy D; Wang TJ; Meigs JB
J Am Coll Cardiol; 2009 Mar; 53(9):754-62. PubMed ID: 19245965
[TBL] [Abstract][Full Text] [Related]
39. Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: insights from the REVE-2 study.
Eschalier R; Fertin M; Fay R; Bauters C; Zannad F; Pinet F; Rossignol P
Circ Heart Fail; 2013 Nov; 6(6):1199-205. PubMed ID: 23983248
[TBL] [Abstract][Full Text] [Related]
40. Serum concentrations of carboxyterminal propeptide of type 1 procollogen and tissue inhibitor of metalloproteinase 1 in patients with dermatomyositis.
Kubo M; Kikuchi K; Fujimoto M; Tamaki K
Arch Dermatol Res; 1998 May; 290(5):253-7. PubMed ID: 9681676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
